Erythropoietin and Anemia Treatment
Erythropoietin and Anemia Treatment is a research topic within Hematology. Science Explorer counts 16k research works in it since 1950. 15.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the role of erythropoietin and its derivatives in the treatment and management of various diseases, including anemia, chronic kidney disease, heart failure, stroke, and cancer. It explores the use of erythropoiesis-stimulating agents, neuroprotective effects, and the impact on hypoxia-inducible factors. Additionally, it addresses the association with iron deficiency and cardiovascular disease.
- Anemia
- Chronic Kidney Disease
- Heart Failure
- Erythropoiesis-Stimulating Agents
- Neuroprotection
- Hypoxia-Inducible Factors
- Cancer Treatment
- Iron Deficiency
- Stroke
- Cardiovascular Disease
- Research works
- 16k fractional, since 1950
- In the world top 10%
- 2.4k per year above
- Top-10% rate
- 15.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +16% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Erythropoietin and Anemia Treatment research?
By volume, the United States and China publish the most (509 and 362 works in 2022–2025).
By volume, 2022–2025
- 1 United States 509 works
- 2 China 362 works
- 3 India 163 works
- 4 Japan 143 works
- 5 United Kingdom 117 works
- 6 Germany 87 works
- 7 Italy 83 works
- 8 France 66 works
- 9 Spain 64 works
- 10 Türkiye 57 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Erythropoietin and Anemia Treatment research?
By volume in 2022–2025, Ain Shams University publishes the most Erythropoietin and Anemia Treatment research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Peking University.
By volume, 2022–2025
- 1 Ain Shams UniversityEgypt 14 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 9 works
- 3 Peking UniversityChina 6 works
- 4 Capital Medical UniversityChina 6 works
- 5 Akebia Therapeutics (United States)United States 6 works
- 6 Harvard UniversityUnited States 6 works
- 7 InsermFrance 6 works
- 8 Emory UniversityUnited States 6 works
- 9 Mayo ClinicUnited States 6 works
- 10 Chinese University of Hong KongHong Kong 6 works
Who are the leading researchers in Erythropoietin and Anemia Treatment?
The most-cited researchers publishing on Erythropoietin and Anemia Treatment include Juan Jesús Carrero, Marcello Tonelli and Piotr Ponikowski.
- 1 Juan Jesús Carrero Sweden 6.5k citations
- 2 Marcello Tonelli Canada 5.9k citations
- 3 Piotr Ponikowski Poland 4.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Erythropoietin and Anemia Treatment research done?
The largest centres of Erythropoietin and Anemia Treatment research in 2022–2025 are Beijing (China), Tokyo (Japan), London (United Kingdom) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Cairo.
Largest cities, 2022–2025
Where it is the local speciality
- CairoEG · 20.4 works3.2×
Location quotient: how much more of its research is in Erythropoietin and Anemia Treatment than the world average.
Where is the best place to study Erythropoietin and Anemia Treatment?
Among universities, judged by research, Ain Shams University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Ain Shams UniversityEgypt | 55.0 | 2.5% | 7.7× | 14 | +17.3% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 45.0 | 14.7% | 3.6× | 9 | +139.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Erythropoietin and Anemia Treatment research growing?
Output in 2018–2022 was 16% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Erythropoietin and Anemia Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.